<p>Corient Private Wealth LLC 在最近向證券交易委員會提交的文件中表示，在第二季度將其在 Lam Research Corporation（NASDAQ:LRCX - 免費報告）股票的持有量降低了 1.1%。該機構投資者在本季度出售了 20,865 股後，持有 1,823,595 股這家半導體公司的股票。截至其最近向證券交易委員會提交的文件，Corient Private Wealth LLC 持有的 Lam Research 約佔 0.14%，價值為 177,511,000 美元。</p>
<ul>
<li>芯片熱潮迴歸：3 只股票有望大幅上漲</li>
</ul>
<p>其他一些大型投資者最近也買賣了 LRCX 的股票。IMG Wealth Management Inc.在第二季度新建了約 26,000 美元的 Lam Research 頭寸。霍華德·休斯醫學研究所（Howard Hughes Medical Institute）在第二季度購買了價值約 27,000 美元的 Lam Research 新股份。Strategic Wealth Investment Group LLC 在第二季度新建了價值 29,000 美元的 Lam Research 頭寸。Delos Wealth Advisors LLC 在第二季度購買了價值 30,000 美元的 Lam Research 新股份。最後，REAP Financial Group LLC 在第二季度新建了價值 31,000 美元的 Lam Research 頭寸。目前，84.61% 的股票由機構投資者持有。</p>
<h2>Lam Research 價格表現</h2>
<p>LRCX 股票週一開盤價為 160.52 美元。Lam Research Corporation 的 12 個月低點為 56.32 美元，12 個月高點為 169.69 美元。該公司的市值為 2016.2 億美元，市盈率為 35.36，市盈增長比率為 1.65，貝塔值為 1.77。該股票的 50 日移動平均線為 152.53 美元，200 日移動平均線為 120.50 美元。該公司的流動比率為 2.21，速動比率為 1.60，債務股本比率為 0.37。</p>
<ul>
<li>應用材料：2025 年上漲 40%，長期有增長空間</li>
</ul>
<p>Lam Research（NASDAQ:LRCX - 獲取免費報告）最近在 10 月 22 日（星期三）發佈了其財報。這家半導體公司報告本季度每股收益為 1.26 美元，超出分析師一致預期的 1.22 美元，超出幅度為 0.04 美元。Lam Research 的股本回報率為 60.60%，淨利潤率為 29.66%。該公司本季度的收入為 53.2 億美元，而分析師預期為 52.3 億美元。在去年同期，該公司每股收益為 0.86 美元。Lam Research 的收入同比增長 27.7%。Lam Research 已將其 2026 年第二季度的指引設定為每股收益 1.050-1.250 美元。整體來看，股票分析師預計 Lam Research Corporation 今年將發佈每股收益 3.71 美元。</p>
<h2>Lam Research 宣佈分紅</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 1 月 7 日（星期三）支付。12 月 3 日（星期三）登記的投資者將獲得 0.26 美元的分紅。該分紅的除息日為 12 月 3 日（星期三）。這相當於年化 1.04 美元的分紅，收益率為 0.6%。Lam Research 的派息比率目前為 22.91%。</p>
<h2>Lam Research 的內部買賣</h2>
<ul>
<li>MarketBeat 週迴顧 – 11/10 - 11/14</li>
</ul>
<p>在其他消息中，首席財務官 Douglas R. Bettinger 於 11 月 14 日（星期五）出售了 40,080 股該股票，交易價格為 150.60 美元，總價值為 6,036,048.00 美元。交易完成後，首席財務官直接持有 987,237 股公司股票，價值約為 148,677,892.20 美元。這代表其持股減少了 3.90%。該出售在向 SEC 的文件中披露，相關信息可通過 SEC 網站獲取。此外，SVP Vahid Vahedi 於 10 月 13 日（星期一）出售了 52,190 股該公司的股票，交易價格為 138.90 美元，總價值為 7,249,191.00 美元。交易完成後，該高級副總裁持有 251,047 股公司股票，價值 34,870,428.30 美元。此交易代表其持股減少了 17.21%。該出售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士出售了 102,608 股公司股票，價值 14,916,496 美元。當前公司內部人士持有 0.31% 的股票。</p>
<h2>華爾街分析師觀點</h2>
<p>幾位股票研究分析師最近對 LRCX 股票發佈了報告。Evercore ISI 在 10 月 23 日（星期四）的研究報告中將 Lam Research 的目標價從 115.00 美元上調至 170.00 美元，並給予該公司 “跑贏大盤” 的評級。Dbs Bank 在 10 月 27 日（星期一）的研究報告中將 Lam Research 的目標價從 119.40 美元上調至 184.20 美元。Cowen 在 10 月 23 日（星期四）的報告中重申了對 Lam Research 股票的 “買入” 評級。Needham &amp; Company LLC 在 10 月 23 日（星期四）的研究報告中將 Lam Research 的目標價從 150.00 美元上調至 160.00 美元，並給予該股票 “買入” 評級。最後，巴克萊在 10 月 20 日（星期一）設定了 Lam Research 的目標價為 142.00 美元，並給予該公司 “持平” 評級。26 位研究分析師對該股票給予了 “買入” 評級，10 位分析師對該公司給予了 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 152.87 美元。</p>
<p><strong>閲讀我們最新的 LRCX 股票分析</strong></p>
<h2>Lam Research 公司簡介</h2>
<p>（免費報告）</p>
<p>Lam Research Corporation 設計、製造、營銷、翻新和服務用於集成電路製造的半導體加工設備。該公司提供 ALTUS 系統，用於沉積適用於鎢金屬化應用的符合性薄膜；SABRE 電化學沉積產品，用於銅互連過渡，提供銅大馬士革製造；SOLA 紫外線熱處理產品，用於薄膜處理；以及 VECTOR 等離子體增強 CVD ALD 產品。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票超過 Lam Research</li>
<li>如何計算投資回報率 (ROI)</li>
<li>Dave &amp; Buster’s 的反轉在雙底突破後進入實施階段</li>
<li>如何購買股票：初學者的逐步指南</li>
<li>3 只在 10 年期國債利率上升時值得購買的金融股票</li>
<li>擁有債券的風險</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
</ul>
<p><strong>想看看其他對 LRCX 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Lam Research Corporation (NASDAQ:LRCX - 免費報告) 的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Lam Research 嗎？</h2>
<p>在考慮 Lam Research 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前購買的股票……而 Lam Research 並不在名單上。</p>
<p>雖然 Lam Research 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

拉姆研究

<p>Corient Private Wealth LLC 在第二季度減少了對 Lam Research Corporation 的持股比例，下降了 1.1%，出售了 20,865 股。Lam Research 的股票開盤價為 160.52 美元，12 個月最高價為 169.69 美元。該公司報告第二季度每股收益為 1.26 美元，超出預期。分析師提高了目標價，Evercore ISI 將其設定為 170.00 美元。Lam Research 宣佈每股季度股息為 0.26 美元</p>

<p>Corient Private Wealth LLC lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,823,595 shares of the semiconductor company's stock after selling 20,865 shares during the quarter. Corient Private Wealth LLC owned about 0.14% of Lam Research worth $177,511,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Corient Private Wealth LLC 在最近向證券交易委員會提交的文件中表示，在第二季度將其在 Lam Research Corporation（NASDAQ:LRCX - 免費報告）股票的持有量降低了 1.1%。該機構投資者在本季度出售了 20,865 股後，持有 1,823,595 股這家半導體公司的股票。截至其最近向證券交易委員會提交的文件，Corient Private Wealth LLC 持有的 Lam Research 約佔 0.14%，價值為 177,511,000 美元。</p>
</div><ul>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
</ul>
<div class="lb-trans"><ul>
<li>芯片熱潮迴歸：3 只股票有望大幅上漲</li>
</ul>
</div><p>A number of other large investors have also recently bought and sold shares of LRCX. IMG Wealth Management Inc. acquired a new position in Lam Research during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research during the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the 2nd quarter valued at $29,000. Delos Wealth Advisors LLC bought a new position in Lam Research in the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC acquired a new position in Lam Research during the 2nd quarter worth $31,000. 84.61% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些大型投資者最近也買賣了 LRCX 的股票。IMG Wealth Management Inc.在第二季度新建了約 26,000 美元的 Lam Research 頭寸。霍華德·休斯醫學研究所（Howard Hughes Medical Institute）在第二季度購買了價值約 27,000 美元的 Lam Research 新股份。Strategic Wealth Investment Group LLC 在第二季度新建了價值 29,000 美元的 Lam Research 頭寸。Delos Wealth Advisors LLC 在第二季度購買了價值 30,000 美元的 Lam Research 新股份。最後，REAP Financial Group LLC 在第二季度新建了價值 31,000 美元的 Lam Research 頭寸。目前，84.61% 的股票由機構投資者持有。</p>
</div><h2>Lam Research Price Performance</h2>
<div class="lb-trans"><h2>Lam Research 價格表現</h2>
</div><p>Shares of LRCX stock opened at $160.52 on Monday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $169.69. The company has a market capitalization of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.65 and a beta of 1.77. The stock has a 50 day moving average of $152.53 and a two-hundred day moving average of $120.50. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.</p>
<div class="lb-trans"><p>LRCX 股票週一開盤價為 160.52 美元。Lam Research Corporation 的 12 個月低點為 56.32 美元，12 個月高點為 169.69 美元。該公司的市值為 2016.2 億美元，市盈率為 35.36，市盈增長比率為 1.65，貝塔值為 1.77。該股票的 50 日移動平均線為 152.53 美元，200 日移動平均線為 120.50 美元。該公司的流動比率為 2.21，速動比率為 1.60，債務股本比率為 0.37。</p>
</div><ul>
<li>Applied Materials: Up 40% in 2025 With Room to Run Long-Term</li>
</ul>
<div class="lb-trans"><ul>
<li>應用材料：2025 年上漲 40%，長期有增長空間</li>
</ul>
</div><p>Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period in the prior year, the company posted $0.86 earnings per share. Lam Research's revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.</p>
<div class="lb-trans"><p>Lam Research（NASDAQ:LRCX - 獲取免費報告）最近在 10 月 22 日（星期三）發佈了其財報。這家半導體公司報告本季度每股收益為 1.26 美元，超出分析師一致預期的 1.22 美元，超出幅度為 0.04 美元。Lam Research 的股本回報率為 60.60%，淨利潤率為 29.66%。該公司本季度的收入為 53.2 億美元，而分析師預期為 52.3 億美元。在去年同期，該公司每股收益為 0.86 美元。Lam Research 的收入同比增長 27.7%。Lam Research 已將其 2026 年第二季度的指引設定為每股收益 1.050-1.250 美元。整體來看，股票分析師預計 Lam Research Corporation 今年將發佈每股收益 3.71 美元。</p>
</div><h2>Lam Research Announces Dividend</h2>
<div class="lb-trans"><h2>Lam Research 宣佈分紅</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research's payout ratio is presently 22.91%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 1 月 7 日（星期三）支付。12 月 3 日（星期三）登記的投資者將獲得 0.26 美元的分紅。該分紅的除息日為 12 月 3 日（星期三）。這相當於年化 1.04 美元的分紅，收益率為 0.6%。Lam Research 的派息比率目前為 22.91%。</p>
</div><h2>Insider Buying and Selling at Lam Research</h2>
<div class="lb-trans"><h2>Lam Research 的內部買賣</h2>
</div><ul>
<li>MarketBeat Week in Review – 11/10 - 11/14</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 11/10 - 11/14</li>
</ul>
</div><p>In other news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company's stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the firm's stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company's stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，首席財務官 Douglas R. Bettinger 於 11 月 14 日（星期五）出售了 40,080 股該股票，交易價格為 150.60 美元，總價值為 6,036,048.00 美元。交易完成後，首席財務官直接持有 987,237 股公司股票，價值約為 148,677,892.20 美元。這代表其持股減少了 3.90%。該出售在向 SEC 的文件中披露，相關信息可通過 SEC 網站獲取。此外，SVP Vahid Vahedi 於 10 月 13 日（星期一）出售了 52,190 股該公司的股票，交易價格為 138.90 美元，總價值為 7,249,191.00 美元。交易完成後，該高級副總裁持有 251,047 股公司股票，價值 34,870,428.30 美元。此交易代表其持股減少了 17.21%。該出售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士出售了 102,608 股公司股票，價值 14,916,496 美元。當前公司內部人士持有 0.31% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several equities research analysts have recently issued reports on LRCX shares. Evercore ISI raised their price target on Lam Research from $115.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, October 23rd. Dbs Bank increased their target price on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Cowen reaffirmed a &#34;buy&#34; rating on shares of Lam Research in a report on Thursday, October 23rd. Needham &amp; Company LLC lifted their price target on Lam Research from $150.00 to $160.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, October 23rd. Finally, Barclays set a $142.00 price objective on Lam Research and gave the company an &#34;equal weight&#34; rating in a research report on Monday, October 20th. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $152.87.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對 LRCX 股票發佈了報告。Evercore ISI 在 10 月 23 日（星期四）的研究報告中將 Lam Research 的目標價從 115.00 美元上調至 170.00 美元，並給予該公司 “跑贏大盤” 的評級。Dbs Bank 在 10 月 27 日（星期一）的研究報告中將 Lam Research 的目標價從 119.40 美元上調至 184.20 美元。Cowen 在 10 月 23 日（星期四）的報告中重申了對 Lam Research 股票的 “買入” 評級。Needham &amp; Company LLC 在 10 月 23 日（星期四）的研究報告中將 Lam Research 的目標價從 150.00 美元上調至 160.00 美元，並給予該股票 “買入” 評級。最後，巴克萊在 10 月 20 日（星期一）設定了 Lam Research 的目標價為 142.00 美元，並給予該公司 “持平” 評級。26 位研究分析師對該股票給予了 “買入” 評級，10 位分析師對該公司給予了 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 152.87 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on LRCX</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 LRCX 股票分析</strong></p>
</div><h2>Lam Research Profile</h2>
<div class="lb-trans"><h2>Lam Research 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.</p>
<div class="lb-trans"><p>Lam Research Corporation 設計、製造、營銷、翻新和服務用於集成電路製造的半導體加工設備。該公司提供 ALTUS 系統，用於沉積適用於鎢金屬化應用的符合性薄膜；SABRE 電化學沉積產品，用於銅互連過渡，提供銅大馬士革製造；SOLA 紫外線熱處理產品，用於薄膜處理；以及 VECTOR 等離子體增強 CVD ALD 產品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Lam Research</li>
<li>How to Calculate Return on Investment (ROI)</li>
<li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li>
<li>How to buy stock: A step-by-step guide for beginners</li>
<li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li>
<li>The Risks of Owning Bonds</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Lam Research</li>
<li>如何計算投資回報率 (ROI)</li>
<li>Dave &amp; Buster’s 的反轉在雙底突破後進入實施階段</li>
<li>如何購買股票：初學者的逐步指南</li>
<li>3 只在 10 年期國債利率上升時值得購買的金融股票</li>
<li>擁有債券的風險</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LRCX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 LRCX 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Lam Research Corporation (NASDAQ:LRCX - 免費報告) 的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=LRCX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Lam Research Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Lam Research 嗎？</h2>
</div><p>Before you consider Lam Research, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Lam Research 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前購買的股票……而 Lam Research 並不在名單上。</p>
</div><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Lam Research 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Corient Private Wealth LLC 出售了 20,865 股拉姆研究公司（Lam Research Corporation）股票，代碼為 $LRCX